Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ENDO 2002 presentations discuss preclinical findings for rexinoid LG-100268

June 26, 2002

Proof of principle for orally active CCKA agonist GI-181771X

June 26, 2002

Transdermal administration of basal insulin through micropores for type 2 diabetes

June 25, 2002

Use of the Aerodose inhaler in type 2 diabetic patients

June 25, 2002

Preparation and use of beta3-adrenoceptor agonists described in Lilly patent

June 25, 2002

Both type 1 and 2 diabetics may benefit from Exubera according to phase III data

June 25, 2002

Microbially produced alpha-glucosidase inhibitor with promising preclinical profile

June 25, 2002

Selective H3 receptor antagonist from Abbott effective in animal model of diet-induced obesity

June 25, 2002

Preclinical and clinical data for DPP-IV inhibitor P-32/98 discussed at ADA meeting

June 25, 2002

Novel long-acting GLP-1 analogue characterized at ADA meeting

June 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...